Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amarin Corporation PLC

AMRN
Current price
0.61 USD +0.016 USD (+2.75%)
Last closed 0.57 USD
ISIN US0231112063
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 194 233 792 USD
Yield for 12 month -49.80 %
1Y
3Y
5Y
10Y
15Y
AMRN
21.11.2021 - 28.11.2021

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Iconic Offices, The Greenway, Dublin, Ireland, 112-114

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.00 USD

P/E ratio

Dividend Yield

Current Year

+306 911 000 USD

Last Year

+369 193 000 USD

Current Quarter

+42 298 000 USD

Last Quarter

+67 566 660 USD

Current Year

+165 541 000 USD

Last Year

+242 484 000 USD

Current Quarter

+16 276 000 USD

Last Quarter

+42 055 093 USD

Key Figures AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -40 873 000 USD
Operating Margin TTM -59.50 %
PE Ratio
Return On Assets TTM -3.45 %
PEG Ratio -1.74
Return On Equity TTM -7.26 %
Wall Street Target Price 1.00 USD
Revenue TTM 241 020 992 USD
Book Value 1.29 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -36.00 %
Dividend Yield
Gross Profit TTM 260 562 000 USD
Earnings per share -0.10 USD
Diluted Eps TTM -0.10 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -94.20 %
Profit Margin -16.33 %

Dividend Analytics AMRN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 18.01.2008
Dividend Date
Consecutive Years
Consistent Years
Continuous Dividends

Stock Valuation AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 500.00
Enterprise Value Revenue 0.076
Price Sales TTM 0.81
Enterprise Value EBITDA -5.80
Price Book MRQ 0.37

Financials AMRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AMRN

For 52 weeks

0.45 USD 1.37 USD
50 Day MA 0.55 USD
Shares Short Prior Month 17 928 735
200 Day MA 0.72 USD
Short Ratio 12.75
Shares Short 17 948 640
Short Percent 4.42 %